There is evidence that the binding of LOX-1, a novel CCT substrate protein with an important link between chronic inflammation and cancer (29), to CCT may activate the inflammatory transcription factor NF-κB, thereby inducing malignant transformation (30). Here, FLVCR2 is linked to cancer.